Navigation Links
Bilateral DePuy Hip Implant Failures Lead to Lawsuit
Date:4/1/2011

AUSTIN, Texas, April 1, 2011 /PRNewswire/ -- Vickie Barber and her husband, Andrew, filed suit today against DePuy Orthopaedics, Inc. and Johnson & Johnson, Inc. seeking compensation for injuries caused by the failures of Vickie's two DePuy ASR XL Acetabular Hip Replacement Systems.  John David Hart of the Law Offices of John David Hart in Fort Worth, Texas, is the attorney representing Vickie and Andrew Barber in the lawsuit filed in the United States District Court for the Western District of Texas in Austin.

In December, 2006, Mrs. Barber underwent hip replacement surgery to have a DePuy ASR XL Acetabular System implanted in her left hip.  In December, 2009, she underwent hip replacement surgery to have a DePuy ASR XL Acetabular System implanted in her right hip.  Since the surgical implantation of the ASR XL Acetabular Hip Replacement Systems, Mrs. Barber has suffered severe and debilitating injuries, including elevated levels of chromium and cobalt in her blood.  She was required to have surgeries to remove both DePuy ASR XL Acetabular Systems from her hips and revise them with other hip replacement systems in November, 2010 and March, 2011.

"Vickie is deeply concerned about the long term effects of the elevated metal ion levels in her blood stream.  These levels were extremely high prior to the devices being replaced," said attorney John David Hart.  "Vickie continues to struggle with problems with both hips even after revision surgeries.  Vickie's life is forever changed as a result of these dangerous, unsafe medical products."

DePuy Orthopaedics, Inc., a division of Johnson and Johnson, Inc., recalled its ASR XL Acetabular metal-on-metal hip replacement system on August 24, 2010. This recall came after data from a recent study indicated that the five year failure rate of this product is approximately 13%, or more than 1 out of every 8 patients. DePuy identified reasons for the failure of the hip replacement system as component loosening, component malalignment, infection, fracture of the bone, dislocation, metal sensitivity and pain. Additional complications from the DePuy ASR XL Acetabular Hip Replacement System may include increased metal ion levels in the blood, bone staining, necrosis, swelling, nerve damage, tissue damage and/or muscle damage.  This device was marketed by DePuy Orthopaedics as a high performance hip replacement system. Recent information published by the British Orthopaedic Association indicates that failure rates at six years may be as high as 49%.

John David Hart and the Law Offices of John David Hart represent many individuals in the United States who have been injured as a result of this defective hip replacement system.  The Law Offices of John David Hart is a group of experienced and dedicated legal professionals working to protect the rights of people wronged by the acts of others.  Across the country, the firm represents individuals in cases of catastrophic personal injury, wrongful death, dangerous drugs and medical products, automobile and truck accidents and oil and gas litigation.  For more information, please contact John David Hart at 800.961.4278 or johnhart@hartlaw.com or visit www.hiprecallinfo.com.


'/>"/>
SOURCE The Law Offices of John David Hart
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. DePuy Orthopaedics Voluntarily Recalls ASR™ Hip System
2. Class Action Lawsuit Filed Against DePuy Orthopaedics, Inc.
3. DePuy Hip Recall & Avandia Focus of Nov. 3 Conference, HB Announces
4. DePuy Orthopaedics Accused of Deceiving Hip Replacement Patients
5. Federal Panel Grants Lanier Law Firm Motion for Hearing on National Coordination of DePuy Hip Implant Lawsuits
6. Chesley Files Class Action Against DePuy Orthopaedics
7. Burg Simpson Leads National Litigation Against DePuy Orthopaedics, Inc.
8. Johnson & Johnson Recall of DePuy Hip Devices: Lewitt Hackman Files Suit
9. Rottenstein Law Group Applauds New Efforts of U.S. FDA to Look More Carefully at Metal-on-Metal Implants After DePuy Recall
10. Woman Files Suit in Federal Court Against DePuy Orthopaedics, Inc.,/Johnson & Johnson Over Recalled Hip Device
11. Woman Files Suit in Beaumont, Texas Federal Court Against DePuy Orthopaedics and Johnson & Johnson Over Recalled Hip Device
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2016)... , Dec. 5, 2016   Lexicon Pharmaceuticals, ... results today from a Phase 2 clinical study of ... Lexicon in collaboration with JDRF, the leading global organization ... of this Phase 2 clinical trial, which randomized a ... of a once-daily 400 mg dose of sotagliflozin compared ...
(Date:12/5/2016)... , December 5, 2016 According to ... Treatment modalities (Chondrocyte Transplantation, Growth Factor Technology, Tissue Scaffolds, Cell-free composites), ... by MarketsandMarkets, the market is projected to reach USD 779.8 Million ... CAGR of 13.5% during the forecast period of 2016 to 2021. ... ...
(Date:12/5/2016)... PORTLAND, Oregon and PUNE, India ... a new report by Allied Market Research, titled, "Global Cancer ... the global revenue of cancer biomarkers market is projected to ... at a CAGR of 13.3% from 2016 to 2022. Omic ... share in 2015 and is expected to maintain its dominance ...
Breaking Medicine Technology:
(Date:12/6/2016)... , ... December 06, 2016 ... ... on Friday, November 25th, when SevenPoint2 released the much-anticipated HydroFX for Water®. ... eye-catching label design. Featuring one of the world’s most powerful antioxidants, molecular ...
(Date:12/6/2016)... ... December 06, 2016 , ... TopConsumerReviews.com recently gave a ... Scooters . , Mobility Scooters give freedom to people who need help getting around. ... may be facing a long period of rehabilitation after an illness or accident. There ...
(Date:12/5/2016)... ... December 05, 2016 , ... "FCPX Overlay Glare is a ... lighting effect without heavy rendering or complicated compositing," said Christina Austin - CEO of ... create an organic spectrum of lights that simulates the look of a glare. ...
(Date:12/5/2016)... GA (PRWEB) , ... December ... ... technology and security executive networking and relationship-marketing firm, announced today that nominations ... the 2017 Information Security Executive® (ISE®) Central Awards. , Awards include the ...
(Date:12/5/2016)... ... December 05, 2016 , ... Physicians Education ... Annual International Congress on Hematologic Malignancies®: Focus on Leukemias, Lymphomas, and Myeloma, on ... “We are honored to have Amy E. Herman present at this year’s conference, ...
Breaking Medicine News(10 mins):